Hydrocephalus: historical analysis and considerations for treatment DOI Creative Commons
Alexandra Hochstetler, Jeffrey S. Raskin, Bonnie L. Blazer‐Yost

и другие.

European journal of medical research, Год журнала: 2022, Номер 27(1)

Опубликована: Сен. 1, 2022

Abstract Hydrocephalus is a serious condition that affects patients of all ages, resulting from multitude causes. While the etiologies hydrocephalus are numerous, many acute and chronic symptoms shared. These include disorientation pain (headaches), cognitive developmental changes, vision sleep disturbances, gait abnormalities. This collective group combined with effectiveness CSF diversion as surgical intervention for types suggest various may share common cellular molecular dysfunctions. The incidence rate pediatric approximately 0.1–0.6% live births, making it Down syndrome in infants. Diagnosis treatment forms adult remain understudied underreported. Surgical interventions to treat hydrocephalus, though lifesaving, have high failure. Previously tested pharmacotherapies resulted net zero or negative outcomes potentially due lack understanding mechanisms contribute development hydrocephalus. Very few well-validated drug targets been proposed therapy; most these within last 5 years. Within 50 years, there only incremental improvements treatments has little progress made towards prevention cure. demonstrates need develop nonsurgical regardless etiology. new paradigms relies heavily on investment researching requires concerted support patient advocacy organizations, government- private-funded research, biotechnology pharmaceutical companies, medical device industry, vast network healthcare professionals.

Язык: Английский

The glymphatic hypothesis: the theory and the evidence DOI Creative Commons
Stephen B. Hladky,

Margery A. Barrand

Fluids and Barriers of the CNS, Год журнала: 2022, Номер 19(1)

Опубликована: Фев. 3, 2022

Abstract The glymphatic hypothesis proposes a mechanism for extravascular transport into and out of the brain hydrophilic solutes unable to cross blood–brain barrier. It suggests that there is circulation fluid carrying inwards via periarterial routes, through interstitium outwards perivenous routes. This review critically analyses evidence surrounding mechanisms involved in each these stages. There good both influx efflux occur along routes but no principal route outflow perivenous. Furthermore, inflow unlikely be adequate provide would needed account solute efflux. A tenet flow sweeps parenchyma. However, velocity any possible circulatory within too small compared diffusion effective movement. By comparison earlier classical describing proposed entry parenchyma across barrier, movements by diffusion, partly near surfaces carried “preferred routes” including perivascular spaces, white matter tracts subependymal spaces. did not suggest Evidence still incomplete concerning fate leaving brain. large proportion eliminated from go lymph nodes before reaching blood proportions delivered directly or indirectly CSF which then enters are as yet unclear. In addition, understood why how absence AQP4 normally highly expressed on glial endfeet lining reduces rates elimination delivery it remote sites injection. Neither nor adequately explain move into, Features more complete description discussed. All aspects require further study.

Язык: Английский

Процитировано

165

A mesothelium divides the subarachnoid space into functional compartments DOI
Kjeld Møllgård, Felix R. M. Beinlich, Peter Kusk

и другие.

Science, Год журнала: 2023, Номер 379(6627), С. 84 - 88

Опубликована: Янв. 5, 2023

The central nervous system is lined by meninges, classically known as dura, arachnoid, and pia mater. We show the existence of a fourth meningeal layer that compartmentalizes subarachnoid space in mouse human brain, designated lymphatic-like membrane (SLYM). SLYM morpho- immunophenotypically similar to mesothelial lining peripheral organs body cavities, it encases blood vessels harbors immune cells. Functionally, close apposition with endothelial venous sinus permits direct exchange small solutes between cerebrospinal fluid blood, thus representing equivalent arachnoid granulations. functional characterization provides fundamental insights into brain barriers transport.

Язык: Английский

Процитировано

160

Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration DOI
John V. Pluvinage, Tony Wyss‐Coray

Nature reviews. Neuroscience, Год журнала: 2020, Номер 21(2), С. 93 - 102

Опубликована: Янв. 8, 2020

Язык: Английский

Процитировано

159

Aging-associated deficit in CCR7 is linked to worsened glymphatic function, cognition, neuroinflammation, and β-amyloid pathology DOI Creative Commons
Sandro Dá Mesquita, Jasmin Herz,

Morgan Wall

и другие.

Science Advances, Год журнала: 2021, Номер 7(21)

Опубликована: Май 21, 2021

Dysfunctional meningeal immunity is associated with cognitive decline, impaired glymphatics, and enhanced Alzheimer’s pathology.

Язык: Английский

Процитировано

120

Hydrocephalus: historical analysis and considerations for treatment DOI Creative Commons
Alexandra Hochstetler, Jeffrey S. Raskin, Bonnie L. Blazer‐Yost

и другие.

European journal of medical research, Год журнала: 2022, Номер 27(1)

Опубликована: Сен. 1, 2022

Abstract Hydrocephalus is a serious condition that affects patients of all ages, resulting from multitude causes. While the etiologies hydrocephalus are numerous, many acute and chronic symptoms shared. These include disorientation pain (headaches), cognitive developmental changes, vision sleep disturbances, gait abnormalities. This collective group combined with effectiveness CSF diversion as surgical intervention for types suggest various may share common cellular molecular dysfunctions. The incidence rate pediatric approximately 0.1–0.6% live births, making it Down syndrome in infants. Diagnosis treatment forms adult remain understudied underreported. Surgical interventions to treat hydrocephalus, though lifesaving, have high failure. Previously tested pharmacotherapies resulted net zero or negative outcomes potentially due lack understanding mechanisms contribute development hydrocephalus. Very few well-validated drug targets been proposed therapy; most these within last 5 years. Within 50 years, there only incremental improvements treatments has little progress made towards prevention cure. demonstrates need develop nonsurgical regardless etiology. new paradigms relies heavily on investment researching requires concerted support patient advocacy organizations, government- private-funded research, biotechnology pharmaceutical companies, medical device industry, vast network healthcare professionals.

Язык: Английский

Процитировано

109